Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment

American Journal of Gastroenterology

Volumn 104, Issue 6, 2009, Pages 1460-1467

  Kulnigg, Stefanie ^a   Teischinger, Lena ^a   Dejaco, Clemens ^a   Waldhör, Thomas ^b   Gasche, Christoph ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medical University of Vienna   (Austria)

^c Abteilung Gastroenterologie and Hepatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; FERRITIN;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT;

ADULT; ANEMIA, IRON-DEFICIENCY; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; FERRITINS; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; INJECTIONS, INTRAVENOUS; IRON; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 66949124302     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.114     Document Type: Article

References (15)

1. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006 ;24 :1507- 23.
2. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin . Annu Rev Nutr 2006; 26: 323- 42.
3. Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron de!ciency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007 ;13 :1545- 53.
4. Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008 ;103 :1299 -307.
5. Dohil R, Hassall E, Wadsworth LD et al. Recombinant human erythropoietin for treatment of anemia of chronic disease in children with Crohn's disease. J Pediatr 1998; 132: 155-9.
6. Horina JH, Petritsch W, Schmid CR et al. Treatment of anemia in infl ammatory bowel disease with recombinant human erythropoietin: results in three patients . Gastroenterology 1993 ;104 :1828- 31.
7. Gasche C, Reinisch W, Lochs H et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron de!ciency. Dig Dis Sci 1994 ;39 :1930-4.
8. Schreiber S, Howaldt S, Schnoor M et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996; 334: 619- 23.
9. Gasche C, Dejaco C, Waldhoer T et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. 1997; 126: 782-7.
10. Koutroubakis IE, Karmiris K, Makreas S et al. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study. Eur J Gastroenterol Hepatol 2006; 18: 421-5.
11. Gasche C, Dejaco C, Reinisch W et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin . Digestion 1999 ;60 :262-7.
12. Gasche C, Waldhoer T, Feichtenschlager T et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia . Am J Gastroenterol 2001 ;96 :2382-7.
13. Ali M, Rigolosi R, Fayemi AO et al. Failure of serum ferritin levels to predict bone-marrow iron content aGer intravenous iron-dextran therapy. Lancet 1982;1: 652-5.
14. Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities . Schweiz Med Wochenschr 1970 ;100 :301-3.
15. Kulnigg S, Stoinov S, Simanenkov V et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008 ;103 :1182- 92.